functional esophageal-and gastric-cancer screening
- Conditions
- C15.9C16.9Oesophagus, unspecifiedStomach, unspecified
- Registration Number
- DRKS00005037
- Lead Sponsor
- Institut für Kreislaufforschung und SportmedizinAbteilung molekulare und zelluläre Sportmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
All patients with esophageal and or gastric cancer which are hospitalised in the department of general and visceral surgery of the university hospital cologne.
-The written consent.
- Patients which are not hospitalised.
- Severe COPD (Gold 3+4)
- Severe Astma bronchiale
- Other severe pulmonary diseases.
- Advanced heart failure (NYHA 3+4)
- Severe coronary heart disease.
- High grade aortic valve stenosis or other high grade cardial valve defects.
- AV block 2°+3° or other high grade cardial conduction defects.
- High grad Tachykardia
- Other high grade cardial underlying diseases.
- Severe Hypertonia.
- Severe osseous instabilities
- Severe neurological or psychological disorders.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring of the physical performance with the modified WHO-Test on a bicycle spiroergometry and comparing the results to an average population.
- Secondary Outcome Measures
Name Time Method - Pulmonary function via pulmonary function test<br>- Strength via One Repetition Maximum Test<br>- Determination of the lactat level from <br> bloodserum<br>- Cytokine patterns via ELISA<br>- Coordination via force-measuring-plate<br>- Cognition via Vienna Test System<br>- Quality of life, fatigue, activity-level via <br> questionnaires